A growth factor-stimulating gene therapy did not improve outcomes with vascularized lymph node transfer (VLNT) for breast cancer-related lymphedema in a small randomized trial, that added to evidence ...
On May 31st, 2018, the Node.js Foundation released its 2018 User Survey Report, with insights from more than 1600 participants, spanning 100+ countries. Usage continues to grow rapidly, with over ¾ of ...
The frequent spread of certain cancers to lymph nodes often necessitates surgery or radiation therapy that damages the lymphatic system and can cause lymphedema, a condition of localized fluid ...
VEGF-inducing gene therapy did not significantly improve outcomes with vascularized lymph node transfer for lymphedema. Arm volume reduction and quality of life were similar between treatment groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results